Biomarkers and Drug Discovery Angie Pannier Mathias Schubert Pat Dussault Surinder Batra.

Slides:

Advertisements

Similar presentations

Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.

Advertisements

Single Molecule Imaging and Tracking for High-Throughput Screening Single Molecule Imaging and Tracking for High-Throughput Screening Greg Bashford Dept.

MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.

Bioscience/Biomedical Research at Idaho State University Christopher Daniels, Ph.D. Director, ISU Biomedical Research Institute and Professor of Pharmaceutical.

Mission-Based Management November 2005 Electronic CV System Users Group.

Medical Health Application Group Members –Stephen Bonasera –Jitender Deogun –Dongming Peng –Jung Yul Lim –Michael Hempel –Tad Wysocki –Beata Wysocki –Joseph.

Charge: Your task is to develop core ideas/projects for an $8-10M ($ M per year for 5 years) NIH Center proposal. Specifically, you should consider.

Environmental Applications Group Members Shawn Gibbs Alan Kolok Keshore Bidasee Yongfeng Lu Yi Qian Shi-Jian Ding Srivatsan Kidambi.

Fungal Semantic Web Stephen Scott, Scott Henninger, Leen-Kiat Soh (CSE) Etsuko Moriyama, Ken Nickerson, Audrey Atkin (Biological Sciences) Steve Harris.

Introduction to Genomics, Bioinformatics & Proteomics Brian Rybarczyk, PhD PMABS Department of Biology University of North Carolina Chapel Hill.

Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.

NICLS: Development of Biomedical Computing and Information Technology Infrastructure Presented by Simon Sherman August 15, 2005.

Charge: Your task is to develop core ideas/projects for an $8-10M ($ M per year for 5 years) NIH Center proposal. Specifically, you should consider.

Challenges in Clinical Applications for Nanotechnology N. Tony Eissa, MD Table 3.

Charge: Your task is to develop core ideas/projects for an $8-10M ($ M per year for 5 years) NIH Center proposal. Specifically, you should consider.

Overview of UNMC Campus Research Activities Howard E. Gendelman, M.D. Professor and Chair, Pharmacology and Experimental Neuroscience, UNMC Howard E. Gendelman,

The Nebraska Center for Rapid Bioanalysis An Overview of the UNMC current COBRE centers and Nanoimaging core facilityAn Overview of the UNMC current COBRE.

NE CENTER FOR NEUROLOGICAL DISORDERS Group Members Tsuneya Ikezu - Dept of Pharmacology - UNMC Yutong Liu -Dept of Radiology - UNMC Li Tan - Engineering.

© NuAge Vision Webwww.nuage-vision.com Tel:+44 (0) (0) Developing.

Epigenetics Core Subhashinee Samudra K. Wijeratne, Ph.D. Dept. of Nutrition and Health Sciences, UNL.

Molecular Library and Imaging Francis Collins, NHGRI Tom Insel, NIMH Rod Pettigrew, NIBIB Building Blocks and Pathways Francis Collins,NHGRI Richard Hodes,

School of Medicine Shared Resource Facilities The School of Medicine provides direct support and oversight to 21 SOM shared resource facilities. Their.

The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.

ENGINEERING ORIENTATION Information on Bioengineering Curriculum and Area Electives Dr. A. Saterbak Dr. K.-Y. San.

Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.

NANOPARTICLES AND NANOSTRUCTURES FOR BIOMEDICAL IMAGING AND THERAPY Design and development of biocompatible and target specific nanoparticles for disease.

Biotechnology SB2.f – Examine the use of DNA technology in forensics, medicine and agriculture.

Biotechnology in Medicine Chapter 12.

Center for Human Health and the Environment

The Nebraska Center for Rapid Bioanalysis An Overview of the NIH COBRE Program David S. Hage COBRE Retreat - January 16, 2009.

Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.

A New Oklahoma Bioinformatics Company. Microarray and Bioinformatics.

Bill Gerwick Research Interests Characterizing the ‘weird and wonderful’ natural products of marine algae and cyanobacteria Drug discovery from marine.

Predicting MicroRNA Genes and Target Site using Structural and Sequence Features: Machine Learning Approach Malik Yousef Institute of Applied Research,

WP 2: ScanBalt Campus Knowledge Centers WP leader: Carita Martin, Turku Bio Valley Ltd (Total budget Euro)

OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.

Image-Guided Interventions; Ultrasound Group Members –Mehrdad Negahban (Eng. Mechs., UNL) –Jiashi Yang (Eng. Mechs., UNL) –Jason MacTaggart (Surgery, UNMC)

SX RNA: USING RNA-BASED, NANO-SWITCHES TO DETECT NOVEL NON-CODING RNA EXPRESSION Scott A. Tenenbaum SUNY- College of Nanoscale Science and Engineering,

Nanotechnology The concept of nanotechnology is defined as an art handling of tiny particles (1nm= m). The structures have different properties.

Pathogenomics How this project began: Ann Rose - take advantage of DNA sequence information - genomics Julian Davies - use the information to understand.

Histone Methyltransferases: Global Industry Report for Research Tools, Diagnostics and Drug Discovery

KEY CONCEPT Genetics provides a basis for new medical _____________.

○ Area Yonsei Biomedical Science and Technology Initiative (YBSTI)

R.I.MacDonald President, Canadian Institute for Photonics Innovation Ottawa Centre for Research and Innovation The Partnership Conference Series: The Photonics.

Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.

+ Melanie Donahue Biomedical Researcher. + Education Graduated from Sturgis in 2007 Researched and applied to undergraduate institutions with strong math.

Methods in Cell Biology Cont. Sept. 24, Science Bomb 2 Unc-22: encodes a myofilament in C. elegans.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Precision Medicine Market worth.

Moiz Bakhiet, MD, PhD, Professor and Chairman

OUHSC Vision/Initiatives for

SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))

AN ATTEMPT TO REVERSE CANCER DRUG RESISTANCE

Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.

From Bench to Clinical Applications: Money Talks

KEY CONCEPT Genetics provides a basis for new medical treatments.

Branko Stefanovic Biomedical Sciences

Nancy Baker SILS Bioinformatics Seminar January 21, 2004

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Introduction to Bioinformatic

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Nanoparticles For Delivery of DNA Therapeutics

12th – 13th November GRANADA

Guidance for Proposers Day Slide

Bio-Rad Overview and Statement of Interests

KEY CONCEPT Genetics provides a basis for new medical treatments.

Center for Clinical and Translational Science

Presentation transcript:

Biomarkers and Drug Discovery Angie Pannier Mathias Schubert Pat Dussault Surinder Batra

Charge: Your task is to develop core ideas/projects for an $8-10M ($ M per year for 5 years) NIH Center proposal. Specifically, you should consider the following questions

Briefly describe the core projects your group would design for the Center. Please dream big. Cancer diagnostics –Noninvasive Imaging-based (small molecules) Blood-borne (cellular or molecular targets) –Detection with nanoparticles and then novel characterization techniques (to determine presence of ligand) –Nanohybrid materials--Biomolecule capturing/filtering/microfluidics/readout techniques –Detection for proteins, miRNAs, small molecules Diagnostics/Disease Screening Center (broader than cancer)—” Nanohybrid Biomaterials for Diagnostics” –Screen for miRNAs –Sensitive RNA detection methods and probes –Sequencing –Profiles –Bioinformatics Personalized Medicine –Combine above with additional therapies

Identify the key faculty from both campuses to involve in these projects. Include their strengths. (UNMC on next slide) UNL FacultyStrengths Pat Dussualt David Hage Mathias Schubert Angie Pannier Eva Bachman-Schubert Ravi Saraf Yongfeng Lu Rebecca Lai Hendrik Viljoen Yuris Dzenis Ming Han Srivatsan Kidambi Dennis Alexander Greg Bashford Shadi Othman Jung Yul Lim

Identify the key faculty from both campuses to involve in these projects. Include their strengths. UNMC Faculty Strengths Surinder Batra Tony Hollingsworth Aaron Sasson Michelle Ouetllet John Davis Steve Remenga Subodh Lele Hamid Band Vimla Band Kay Wagner Ken Cowan CDDN (Sasha Kabanov and Tatiana Bronich) Sanjay Singh Howard Gendelman Ken Bayles

Identify external academic partners & expertise or equipment resources/strengths that are needed to accomplish these projects. Better communication between campuses (and PIs) Expand nanofabrication facilities (microelectronics, prototyping) Microfluidics faculty member New graduate program

List potential industry/foundation partners (think broadly) and what they would contribute. Include reasons why they would be interested. J.A. Woollam Co. LICOR P & G Abbott PanCan American Cancer Society All disease specific….

Describe how you would link the Center to other campus resources. Links to CDDN, NCMN, MR-SEC, Center for Biotechnology, Nebraska Gateway for Nutrigenomics, UNMC Bioinformatics, Center for Neurosciences, Genetics Center

Increase communication between campuses (intracampus) “Stanford BioDesign” analogy Poster Sessions Research talks Biologists/clinicians: What are the problems? Engineers: What are the tools?